Quarterly report pursuant to Section 13 or 15(d)

5. Hybrid Debt Instrument (Details Narrative)

v3.7.0.1
5. Hybrid Debt Instrument (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Hybrid debt instruments outstanding $ 0   $ 0   $ 0
Loss on conversion of debt $ 0 $ (6,187,337) $ 0 $ (6,187,337)  
Pharmsynthez [Member]          
Stock issued for convertible note, shares issued     125,397    
Hybrid Debt Instrument [Member] | Pharmsynthez [Member]          
Stock issued for convertible note, shares issued         1,373,036
Stock issued for convertible note, amount converted         $ 6,500,000
Accrued interest converted         $ 200,000